Page last updated: 2024-11-06

perfluidone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

perfluidone: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID37869
CHEBI ID82181
SCHEMBL ID54171
MeSH IDM0057086

Synonyms (40)

Synonym
methanesulfonamide, 1,1,1-trifluoro-n-[2-methyl-4-(phenylsulfonyl)phenyl]-
perfluidone
1,1,1-trifluoro-n-(4-phenylsulphonyl-o-tolyl)methanesulphonamide
(r)-methyl-n-benzoyl-n-(3-chloro-4-fluorophenyl)alaninate
einecs 253-718-3
destun
methanesulfonamide, n-(4-phenylsulfonyl-o-tolyl)-1,1,1-trifluoro-
1,1,1-trifluoro-2'-methyl-4'-(phenylsulphonyl)methanesulphonanilide
epa pesticide chemical code 108001
n-(4-phenylsulfonyl-o-tolyl)-1,1,1-trifluoromethanesulfonamide
1,1,1-trifluoro-2'-methyl-4'-(phenylsulfonyl)methanesulfonanilide
methyl-n-benzoyl-n-(3-chloro-4-fluorophenyl)alaninate, (r)-
1,1,1-trifluoro-n-(2-methyl-4-(phenylsulfonyl)phenyl)methanesulfonamide
methanesulfonamide, 1,1,1-trifluoro-n-(2-methyl-4-(phenylsulfonyl)phenyl)-
perfluidone [ansi:bsi:iso]
wl 43423
mbr 8251
2-methyl-4-(phenylsulfonyl)trifluoromethanesulfonanilide
sb 1528
1,1,1-trifluoro-n-(4-phenylsulfonyl-o-tolyl)methanesulfonamide
caswell no. 903d
brn 2180629
1,1,1-trifluoro-4'-(phenylsulfonyl)methanesulfono-o-toluidide
n-[4-(benzenesulfonyl)-2-methylphenyl]-1,1,1-trifluoromethanesulfonamide
37924-13-3
C19054
unii-7x0f4lz22b
7x0f4lz22b ,
perfluidone [iso]
sb-1528
mbr-8251
destun (3m)
perfluidone [mi]
SCHEMBL54171
CHEBI:82181
trifluoro-n-[2-methyl-4-(phenylsulfonyl)phenyl]methanesulfonamide #
DTXSID3042267
perf luidone
Q22808510
AKOS040753463
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
sulfonamideAn amide of a sulfonic acid RS(=O)2NR'2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (85.71)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.02 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]